530 related articles for article (PubMed ID: 31304554)
21. Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma.
Rajendra S; Xuan W; Hufnagel K; Sharma P; Pavey D; Alhajjiri N; Rattan A; Wang B
Ann N Y Acad Sci; 2020 Jun; 1470(1):44-56. PubMed ID: 32170783
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens.
Antonsson A; Knight L; Whiteman DC;
Cancer Epidemiol; 2016 Apr; 41():96-8. PubMed ID: 26895084
[TBL] [Abstract][Full Text] [Related]
23. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue.
Bowman CJ; Zhang R; Balitzer D; Wang D; Rabinovitch PS; Kővári BP; Mattis AN; Kakar S; Lauwers GY; Choi WT
Mod Pathol; 2021 Oct; 34(10):1889-1900. PubMed ID: 34108638
[TBL] [Abstract][Full Text] [Related]
24. Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer.
Rajaram R; Hofstetter WL
Thorac Surg Clin; 2018 Nov; 28(4):473-480. PubMed ID: 30268293
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
Dunbar KB
Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
29. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
30. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation for Barrett's esophagus-related neoplasia.
Krajciova J; Vackova Z; Spicak J; Martinek J
Minerva Chir; 2018 Aug; 73(4):366-377. PubMed ID: 29806757
[TBL] [Abstract][Full Text] [Related]
32. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
[TBL] [Abstract][Full Text] [Related]
33. [Radio frequency ablation of Barrett's esophagus--can the risk of esophageal adenocarcinoma be reduced?].
Salminen P; Räsänen J; Ristimäki A; Saarnio J; Heikkinen M; Laine S; Koivisto T; Färkkilä M
Duodecim; 2014; 130(6):557-64. PubMed ID: 24724454
[TBL] [Abstract][Full Text] [Related]
34. Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy.
Omar M; Thaker AM; Wani S; Simon V; Ezekwe E; Boniface M; Edmundowicz S; Obuch J; Cinnor B; Brauer BC; Wood M; Early DS; Lang GD; Mullady D; Hollander T; Kushnir V; Komanduri S; Muthusamy VR
Gastrointest Endosc; 2019 Sep; 90(3):395-403. PubMed ID: 31004598
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
36. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
Pouw RE; Gondrie JJ; Rygiel AM; Sondermeijer CM; ten Kate FJ; Odze RD; Vieth M; Krishnadath KK; Bergman JJ
Am J Gastroenterol; 2009 Jun; 104(6):1366-73. PubMed ID: 19491850
[TBL] [Abstract][Full Text] [Related]
37. Barrett's oesophagus: can meaningful screening and surveillance guidelines be formulated based on new data and rejigging the old paradigm?
Rajendra S
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):65-75. PubMed ID: 25743457
[TBL] [Abstract][Full Text] [Related]
38. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]